Psychotic Disorders - Southeast Asia

Revenue in the Psychotic Disorders market is projected to reach US$286.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.03%, resulting in a market volume of US$286.10m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$62.71 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Southeast Asia is experiencing significant growth and development. Customer preferences in the Psychotic Disorders market in Southeast Asia are driven by several factors. Firstly, there is a growing awareness and understanding of mental health issues in the region, leading to increased demand for diagnosis and treatment of psychotic disorders. Additionally, there is a shift towards more personalized and patient-centric healthcare, with individuals seeking treatment options that are tailored to their specific needs. This includes a preference for non-invasive and non-pharmacological interventions, such as cognitive-behavioral therapy and psychoeducation. Furthermore, there is a desire for holistic approaches to mental health, with an emphasis on overall well-being and quality of life.Several trends are shaping the Psychotic Disorders market in Southeast Asia. One key trend is the adoption of digital health technologies. Telemedicine and online therapy platforms are becoming increasingly popular, providing convenient and accessible options for individuals seeking treatment for psychotic disorders. This trend is particularly relevant in Southeast Asia, where access to mental healthcare services can be limited in remote or rural areas. Another trend is the integration of traditional and alternative therapies into mainstream healthcare. Practices such as acupuncture, herbal medicine, and mindfulness meditation are being incorporated into treatment plans, offering patients a wider range of options. Additionally, there is a growing focus on early intervention and prevention strategies, as research suggests that early detection and treatment can lead to better outcomes for individuals with psychotic disorders.Local special circumstances in Southeast Asia can influence the development of the Psychotic Disorders market. Cultural beliefs and stigma surrounding mental health can impact the willingness of individuals to seek help and adhere to treatment plans. Addressing these cultural barriers through education and awareness campaigns is crucial to ensure that individuals receive the support they need. Additionally, the availability and affordability of mental healthcare services vary across countries in the region. Governments and healthcare providers need to work together to improve access to quality care and reduce financial barriers.Underlying macroeconomic factors also play a role in the development of the Psychotic Disorders market in Southeast Asia. Economic growth and increasing disposable incomes contribute to greater healthcare spending, including mental health services. Additionally, government initiatives and policies aimed at improving mental healthcare infrastructure and services can drive market growth. However, economic disparities within the region can create inequalities in access to care, highlighting the need for targeted interventions to ensure equitable healthcare delivery.In conclusion, the Psychotic Disorders market in Southeast Asia is experiencing growth and development driven by customer preferences for personalized and holistic care, as well as the adoption of digital health technologies. Trends such as the integration of traditional and alternative therapies and a focus on early intervention are shaping the market. Local special circumstances, including cultural beliefs and access to care, need to be addressed to ensure that individuals receive appropriate support. Economic factors, such as increasing healthcare spending and government initiatives, also influence the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.